74 results match your criteria: "Child Health Evaluation and Research (CHEAR) Center[Affiliation]"
Child Obes
October 2024
Susan B. Meister Child Health Evaluation and Research (CHEAR) Center, University of Michigan Health, Ann Arbor, Michigan, USA.
Poor body image is a prominent issue affecting youth. In this nationally representative online survey, we explored parents' concerns about their child's appearance, as well as their perceptions of their child's body image concerns and related behaviors and interactions with others. Among the 1653 respondents, weight was parents' most cited body image concern, while more parents perceived that their child was self-conscious about their weight than there were parents concerned about their child's weight.
View Article and Find Full Text PDFJ Pediatr Urol
December 2024
Susan B. Meister Child Health Evaluation and Research (CHEAR) Center, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Division of Pediatric Psychology, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address:
Background: Disorders/Differences of Sex Development (DSD) encompass congenital conditions with atypical development of chromosomal, gonadal, or anatomical sex. Due to the rarity and complexity of these conditions, strong evidence for clinical practices is scarce, leading to controversies in management.
Objective: This study, part of a broader project, examines changes over time in the attitudes and beliefs of DSD healthcare providers, focusing on factors contributing to patients' life satisfaction and the influence of medical specialty, gender, and age.
Pediatr Blood Cancer
October 2024
Susan B Meister Child Health Evaluation and Research (CHEAR) Center, University of Michigan, Ann Arbor, Michigan, USA.
This study examined associations between emergency department (ED) visits and social vulnerability index (SVI) among Michigan's population with sickle cell disease (SCD) using data from the Michigan Sickle Cell Data Collection program (n = 3658 in 2018). SVI was higher among census tracts where people with SCD resided (mean SVI = 0.67; SD = 0.
View Article and Find Full Text PDFPediatr Nephrol
December 2024
Department of Pediatrics, University of Washington, Seattle, WA, USA.
Importance: Pediatric patients with complex medical problems benefit from pediatric sub-specialty care; however, a significant proportion of children live greater than 80 mi. away from pediatric sub-specialty care.
Objective: To identify current knowledge gaps and outline concrete next steps to make progress on issues that have persistently challenged the pediatric nephrology workforce.
BMC Anesthesiol
June 2024
Department of Anesthesiology, Pediatric Division, C.S. Mott Children's Hospital, University of Michigan, 4-911 Mott Hospital / 1540 E. Hospital Dr, SPC 4245, Ann Arbor, MI, 48109, USA.
Background: Sugammadex is a pharmacologic agent that provides rapid reversal of neuromuscular blockade via encapsulation of the neuromuscular blocking agent (NMBA). The sugammadex-NMBA complex is primarily cleared through glomerular filtration from the kidney, raising the possibility that alterations in renal function could affect its elimination. In pediatric patients, the benefits of sugammadex have led to widespread utilization; however, there is limited information on its application in pediatric renal impairment.
View Article and Find Full Text PDFPediatrics
April 2024
Department of Pediatrics, Susan B Meister Child Health Evaluation and Research (CHEAR) Center, University of Michigan, Ann Arbor, Michigan.
J Public Health Manag Pract
January 2024
Child Health Evaluation and Research (CHEAR) Center, University of Michigan, Ann Arbor, Michigan (Dr Dombkowski); HLN Consulting LLC, Mission Viejo, California (Dr Arzt);and Oregon Health Authority, Portland, Oregon (Mr Robison).
ASAIO J
July 2024
Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, Canada.
JAMA Netw Open
January 2024
Susan B. Meister Child Health Evaluation and Research (CHEAR) Center, University of Michigan, Ann Arbor.
ASAIO J
January 2024
University of Tennessee Health Science Center, Le Bonheur Children's Hospital, Memphis, Tennessee.
The Extracorporeal Life Support Organization (ELSO) registry which collects data from hundreds of participating centers supports research in ECMO to help improve patient outcomes. The ELSO Scientific Oversight Committee, an international and diverse group of ECMOlogists ( https://www.elso.
View Article and Find Full Text PDFPediatr Res
February 2024
Department of Pediatrics, Pediatric Critical Care Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
Pediatr Pulmonol
December 2023
Department of Pharmacy Services, Michigan Medicine, Ann Arbor, Michigan, USA.
Safety and efficacy data regarding cystic fibrosis transmembrane conductance regulator (CFTR) modulator use in the setting of pregnancy or breastfeeding remains lacking due to exclusion from key trials and lack of multicenter prospective and retrospective studies in the post-CFTR modulator era. A scoping review of English articles from the period of January 1, 2012, to July 31, 2023, was conducted utilizing PubMed and EmBase databases with the following terms: "special population (pregnancy, lactation, breastfeeding)" AND "ivacaftor OR lumacaftor OR tezacaftor OR elexacaftor"; "cystic fibrosis transmembrane conductance regulator" AND "off label drug use." Search results were reviewed by title and abstract for duplications and relevance.
View Article and Find Full Text PDFPediatr Pulmonol
December 2023
Department of Pharmacy Services, Michigan Medicine, Ann Arbor, Michigan Medicine, USA.
Safety and efficacy data surrounding cystic fibrosis transmembrane regulator (CFTR) modulator administration for people with CF (pwCF) and severe lung disease elect has remained unclear as a result of exclusion from key trials. A scoping review of English language articles from the period of 1 January 2012, to 31 July 2023 was conducted utilizing PubMed and EmBase databases with the following terms: "severe lung disease" OR "advanced lung disease" AND "ivacaftor OR lumacaftor OR tezacaftor OR elexacaftor"; "cystic fibrosis transmembrane conductance regulator" AND "off label drug use." Search results were reviewed by title and abstract for relevance.
View Article and Find Full Text PDFCompr Psychiatry
November 2023
Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, MI, USA; Susan B. Meister Child Health Evaluation and Research (CHEAR) Center, University of Michigan, Ann Arbor, MI, USA.
Background: To explore the preferences of pediatricians for key factors around the implementation of universal routine screening guidelines for major depressive disorder in adolescent patients in a primary care setting.
Method: Semi-structured qualitative interviews were conducted with U.S.
Pediatr Blood Cancer
November 2023
Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
J Public Health Policy
September 2023
University of Michigan College of Pharmacy; Susan B. Meister Child Health Evaluation and Research (CHEAR) Center, University of Michigan, Ann Arbor, MI, USA.
Several states in the United States (U.S.) have laws permitting stock inhalers, including short-acting beta-agonist inhalers, such as albuterol, and spacers to be prescribed to, dispensed to, and stocked in schools for use in students in respiratory distress, based on a protocol.
View Article and Find Full Text PDFJAMIA Open
July 2023
Duke University School of Nursing, Durham, North Carolina, USA.
Objective: Population-level data on sickle cell disease (SCD) are sparse in the United States. The Centers for Disease Control and Prevention (CDC) is addressing the need for SCD surveillance through state-level Sickle Cell Data Collection Programs (SCDC). The SCDC developed a pilot common informatics infrastructure to standardize processes across states.
View Article and Find Full Text PDFPediatr Crit Care Med
May 2023
Pediatric Intensive Care Unit, Bambino Gesù Hospital, IRCCS, Rome, Italy.
Value Health
August 2023
Center for the Evaluation of Value and Risk in Health (CEVR), Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA; Department of Medicine, Tufts University School of Medicine, Boston, MA, USA.
Pediatr Pulmonol
December 2023
Department of Pharmacy Services, Michigan Medicine, Ann Arbor, Michigan, USA.
Background: Solid organ transplant (SOT) recipients with cystic fibrosis (CF) may benefit from the pulmonary and extrapulmonary benefits associated with CF transmembrane conductance regulator modulators. Nevertheless, evolution of modulator safety and efficacy data prompts consideration.
Methods: The search terms "transplant" AND "ivacaftor"(IVA) OR "lumacaftor"(LUM) OR "tezacaftor" (TEZ) OR "elexacaftor" (ELX) were utilized to conduct a scoping review of English articles from the period of January 1, 2012 to December 31, 2022.
Pediatr Blood Cancer
July 2023
Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, United States.
Objective: Hydroxyurea lowers the incidence of vaso-occlusive pain crises (VOC) and acute chest syndrome (ACS) among children with sickle cell anemia (SCA). Our objective was to assess the relationship between levels of adherence to hydroxyurea and clinical outcomes among children and adolescents with SCA.
Methods: This retrospective cohort study included Medicaid data (2005-2012) from Florida, Illinois, Louisiana, Michigan, South Carolina, and Texas.
Prev Sci
October 2023
Department of Human Sciences, College of Education and Human Ecology, The Ohio State University, Columbus, OH, USA.
The rapid rise in opioid misuse, disorder, and opioid-involved deaths among older adolescents and young adults is an urgent public health problem. Prevention is a vital part of the nation's response to the opioid crisis, yet preventive interventions for those at risk for opioid misuse and opioid use disorder are scarce. In 2019, the National Institutes of Health (NIH) launched the Preventing Opioid Use Disorder in Older Adolescents and Young Adults cooperative as part of its broader Helping to End Addiction Long-term (HEAL) Initiative ( https://heal.
View Article and Find Full Text PDFJ Pediatr Gastroenterol Nutr
January 2023
the Division of Pediatric Hepatology, Mount Sinai Kravis Children's Hospital, Icahn School of Medicine at Mount Sinai, New York, NY.
Advances in medical therapies and liver transplantation have resulted in a greater number of pediatric patients reaching young adulthood. However, there is an increased risk for medical complications and morbidity surrounding transfer from pediatric to adult hepatology and transplant services. Health care transition (HCT) is the process of moving from a child/family-centered model of care to an adult or patient-centered model of health care.
View Article and Find Full Text PDFHum Vaccin Immunother
November 2022
Susan B. Meister Child Health Evaluation and Research (CHEAR) Center, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA.
The Advisory Committee on Immunization Practices (ACIP) recommends recombinant zoster vaccine (RZV) to prevent against herpes zoster (HZ) and related complications in immunocompetent adults ≥50 y and immunocompromised adults ≥19 y. In 2019, a statistical safety signal for Guillain-Barré syndrome (GBS) following RZV was identified using data from the Vaccine Safety Datalink (VSD). Subsequently, the U.
View Article and Find Full Text PDFAcad Pediatr
April 2022
Boston Children's Hospital (S Liu and SL Toomey), Boston, Mass; Harvard Medical School (SL Toomey), Boston, Mass.
Background: Measuring quality at varying levels of the health care system requires attribution, a process of determining the patients and services for which each level is responsible. However, it is important to ensure that attribution approaches are equitable; otherwise, individuals may be assigned differentially based upon social determinants of health.
Methods: First, we used Medicaid claims (2010-2018) from Michigan to assess the proportion of children with sickle cell anemia who had less than 12 months enrollment within a single Medicaid health plan and could therefore not be attributed to a specific health plan.